4005 logo

Sumitomo Chemical Company, Limited Stock Price

TSE:4005 Community·JP¥819.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

4005 Share Price Performance

JP¥500.40
164.90 (49.15%)
JP¥533.27
Fair Value
JP¥500.40
164.90 (49.15%)
6.2% undervalued intrinsic discount
JP¥533.27
Fair Value
Price JP¥500.40
AnalystConsensusTarget JP¥533.27
AnalystHighTarget JP¥724.72
AnalystLowTarget JP¥320.00

4005 Community Narratives

AnalystConsensusTarget·
Fair Value JP¥533.27 6.2% undervalued intrinsic discount

Earnings Outlook And Discount Rate Adjustments Will Shape Market Direction

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AnalystHighTarget·
Fair Value JP¥724.72 31.0% undervalued intrinsic discount

Digitization And Green Shifts Will Fuel Material And Crop Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value JP¥320 56.4% overvalued intrinsic discount

Legacy Petrochemical Divisions Will Face Escalating Compliance Costs

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
JP¥724.72
31.0% undervalued intrinsic discount
Revenue
4.37% p.a.
Profit Margin
5.01%
Future PE
10.82x
Price in 2029
JP¥924.71
JP¥533.27
6.2% undervalued intrinsic discount
Revenue
0.42% p.a.
Profit Margin
3.87%
Future PE
11.53x
Price in 2028
JP¥678.04
JP¥320
56.4% overvalued intrinsic discount
Revenue
-2.34% p.a.
Profit Margin
1.85%
Future PE
15.47x
Price in 2028
JP¥409.51

Trending Discussion

Updated Narratives

4005 logo

4005: Glass Core Joint Venture Is Expected To Drive Future Upside

Fair Value: JP¥724.72 31.0% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
4005 logo

4005: Glass Core Joint Venture Will Support Future Earnings Upside

Fair Value: JP¥533.27 6.2% undervalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
4005 logo

Legacy Petrochemical Divisions Will Face Escalating Compliance Costs

Fair Value: JP¥320 56.4% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with adequate balance sheet.

3 Risks
4 Rewards

Sumitomo Chemical Company, Limited Key Details

JP¥2.5t

Revenue

JP¥1.7t

Cost of Revenue

JP¥721.4b

Gross Profit

JP¥636.6b

Other Expenses

JP¥84.8b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 03, 2026
51.80
29.32%
3.45%
101.0%
View Full Analysis

About 4005

Founded
1913
Employees
29279
CEO
Nobuaki Mito
WebsiteView website
www.sumitomo-chem.co.jp

Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity aluminum and alumina, specialty chemicals, additives, engineering plastics, and battery materials, etc. The Advanced Medical Solutions segment offers contract development and manufacturing organization business for small-molecule active ingredients and intermediates, oligonucleic acid drug substances, and regenerative medicine, and cell therapy products, etc. The Essential & Green Materials segment offers synthetic resins, raw materials for synthetic fibers, various industrial chemicals, methyl methacrylate products, synthetic resin processed products, industrial aluminum and alumina, and synthetic rubber, etc. The Sumitomo Pharma segment offers small molecule pharmaceuticals. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.

Recent 4005 News & Updates

Sumitomo Chemical Company (TSE:4005) Takes On Some Risk With Its Use Of Debt

Jan 07
Sumitomo Chemical Company (TSE:4005) Takes On Some Risk With Its Use Of Debt

Recent updates

No updates